PDF(Pubmed)
Abstract：
Parturients with both ankylosing spondylitis (AS) and SARS-CoV-2 Infection (COVID-19) present unique challenges to anesthesiologists. Neuraxial analgesia for labor remains the gold standard in obstetric patients. However, in patients with AS, this approach may be deemed difficult to impossible. Administration of systemic opioids for labor analgesia can be an option, bearing in mind the potential respiratory depressant effect to both the mother and the fetus, especially in the setting of concomitant COVID-19. This paper reports the successful management of such a patient using patient-controlled analgesia (PCA) with intravenous remifentanil.
摘要：
患有强直性脊柱炎（AS）和SARS-CoV-2感染（COVID-19）的产妇给麻醉师带来了独特的挑战。分娩的神经轴镇痛仍然是产科患者的金标准。然而,在AS患者中，这种方法可能被认为是困难的，也可能是不可能的。全身阿片类药物用于分娩镇痛可以是一种选择，考虑到对母亲和胎儿的潜在呼吸抑制作用，特别是在合并COVID-19的情况下。本文报道了使用静脉瑞芬太尼的患者自控镇痛（PCA）成功治疗此类患者。
